Search Results
Dec 06, 2025, 09:30 ET Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
reaction.Immune effector cell-associated enterocolitis (IEC-EC) has occurred in patients treated with CARVYKTI®. Manifestations include severe or prolonged diarrhea, abdominal pain, and weight loss requiring parenteral nutrition. IEC-EC has been associated with fatal outcome from perforation
More news about: Johnson & Johnson
Dec 05, 2025, 16:15 ET Sedai Announces Support for AWS Lambda Managed Instances
AWS Lambda Managed Instances enables Lambda functions to run on Amazon Elastic Compute Cloud (EC2) hardware, including graphics processing units (GPUs) and Graviton4. By combining this technology with Sedai's behavior-driven analytics, customers gain
More news about: Sedai
Dec 05, 2025, 12:42 ET SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2
on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). The information document has been prepared in accordance with the requirements of Annex IX of the
More news about: SciBase
Dec 05, 2025, 09:00 ET Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
effect in humans are unknown. Epidiolex was approved by the U.S. Food and Drug Administration (FDA) for use in the U.S., the European Commission (EC) for use in Europe, the Medicines and Healthcare products Regulatory Agency (MHRA) for use in Great Britain, the Therapeutic Goods Administration for
More news about: Jazz Pharmaceuticals plc
Dec 05, 2025, 05:00 ET EC Power und Sigenergy starten Partnerschaft für integrierte Energie- und Speicherlösungen in Wohn-, Gewerbe- und Industriegebäuden
Speicherhersteller Sigenergy und EC Power GmbH, ein führender Hersteller von Blockheizkraftwerken (BHKW), geben ihre strategische Partnerschaft bekannt. Ziel sind ganzheitlichen Energie- und Heizlösung für Wohn-, Gewerbe- und Industriegebäude, die das XRGI®-Blockheizkraftwerk (BHKW) von EC Power mit dem modularen
More news about: Sigenergy Technology Co., Ltd.
Dec 05, 2025, 05:00 ET Sigenergy präsentiert starke Partnerschaften und Produktneuheiten auf der Solarsolutions Düsseldorf 2025
setzt neue Maßstäbe für innovative Systemarchitekturen im Utility-Scale-Segment.2. Strategische Partnerschaft: Sigenergy x EC Power (XRGI®-BHKW)Mit EC Power GmbH, einem der führenden Hersteller von Blockheizkraftwerken, wurde eine strategische Partnerschaft geschlossen. Ziel ist eine
More news about: Sigenergy Technology Co., Ltd.
Dec 04, 2025, 23:10 ET Hydrogen-Powered Heavy Machinery Market worth USD 25.6 BN by 2032 | Credence Research
sustained growth in a rapidly evolving global economy.Contact UsCredence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Dec 04, 2025, 15:04 ET Zilliz Selects AWS as its Strategic Cloud Provider to Power Global Vector Database Solutions
improvements in resource configuration, elastic architecture, and cost optimization. Zilliz Cloud utilizes various Amazon Elastic Compute Cloud (Amazon EC2) instance types to offer performance-optimized, capacity-optimized, and storage-optimized solutions for different workload requirements. Through Amazon
More news about: Zilliz
Dec 04, 2025, 13:19 ET Com portfólio York, Johnson Controls lidera esforços de descarbonização e sustentabilidade de grandes construções no Brasil
velocidade constante, garante resposta mais precisa e menor consumo de energia.Ventiladores EC de Alta EficiênciaVentiladores de comutação eletrônica (EC) usam motores eficientes e aerodinâmica aprimorada, melhorando o desempenho energético e acústico, especialmente em
More news about: Johnson Controls
Dec 03, 2025, 22:12 ET AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD 17,867.16 MN by 2032 | Credence Research
sustained growth in a rapidly evolving global economy.Contact UsCredence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Dec 03, 2025, 11:40 ET Transurban Finance Company Pty Ltd announces the pricing and early acceptance results of its cash tender offer for its outstanding US$550,000,000 3.375% Guaranteed Senior Secured Notes due 2027
Merrill Lynch International 2 King Edward StreetLondon EC1A 1HQUnited KingdomAttention:
More news about: Transurban Finance Company Pty Ltd
Dec 03, 2025, 09:07 ET EC Electric Honored with NECA Zero Injuries & Safety Excellence Award
of every EC Electric employee who makes safety their top priority every day," said Amanda Davies, Corporate Safety Director at EC Electric. "Achieving zero injuries is not just a milestone – it is proof of our commitment to building a culture of care, vigilance, and accountability."EC Electric
More news about: EC Electric
Dec 03, 2025, 03:33 ET Transurban Finance Company Pty Ltd announces the early tender results of its cash tender offer for its outstanding US$550,000,000 3.375% Guaranteed Senior Secured Notes due 2027, increase to the Maximum Acceptance Amount and election of early settlement
Merrill Lynch International 2 King Edward StreetLondon EC1A 1HQUnited Kingdom
More news about: Transurban Finance Company Pty Ltd
Dec 02, 2025, 19:43 ET Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®
XOLAIR.[1] OMLYCLO was approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) in March 2025 and May 2024, respectively.INDICATIONOMLYCLO® (omalizumab-igec) injection, is an anti-IgE antibody indicated
More news about: Celltrion
Dec 02, 2025, 13:44 ET Biodegradable Industrial Polymers for Circular Economy Applications Market worth USD 48.56 BN by 2032 | Credence Research
sustained growth in a rapidly evolving global economy.Contact UsCredence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Dec 02, 2025, 09:00 ET 넥스트레벨에비에이션®, PNC 은행서 8000만 달러 규모 신용 한도 증액 확보
content:https://www.prnewswire.com/kr/news-releases/uB125uC2A4uD2B8uB808uBCA8uC5D0uBE44uC5D0uC774uC158u00AEu002Cu002Du0070u006Eu0063u002DuC740uD589uC11Cu002Du0038u0030u0030u0030uB9CCu002DuB2EC-302629094.htmlSOURCE
More news about: Next Level Aviation
Dec 02, 2025, 09:00 ET CarbonBuilt Launches Commercial Production of Low Carbon Concrete Products in Connecticut
manufacturing facility in Danielson, CT using its Reversa® binder technology. The company's normal weight concrete masonry has been rated by EC3 as having the lowest carbon footprint in the U.S.
More news about: CarbonBuilt
Dec 02, 2025, 07:53 ET Cosmo und Glenmark geben die Marktzulassung von Winlevi® (Clascoteron) 10 mg/g Creme zur Behandlung von Akne in 17 Ländern in Europa bekannt
-- Cosmo Pharmaceuticals N.V. (SIX: COPN) („Cosmo") und Glenmark Pharmaceuticals Limited („Glenmark") gaben bekannt, dass die Europäische Kommission (EC) die Marktzulassung (MA) für Winlevi® (Clascoteron 10 mg/g Creme) erteilt hat, nachdem der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittelagentur
More news about: Glenmark Pharmaceuticals
Dec 01, 2025, 14:18 ET Quantum Computing-As-A-Service (QCaaS) Market to Reach USD 18,598.33 million by 2032 at 33.88% CAGR - Credence Research
way and understand their most imperative objectives.Contact UsCredence Research Europe LTD128 City Road, London,EC1V 2NX, UNITED KINGDOMEurope - +44 7809 866 263North America - +1 304 308 1216Australia - +61 4192 46279Asia Pacific -
More news about: Credence Research Inc.
Dec 01, 2025, 10:33 ET CloudZero Opens The Age Of Agentic FinOps With New AI Capabilities
in the AI era.CloudZero's NLP features can answer questions like:Resource costs: "How much did we spend on AWS EC2 last month, and which teams drove the increase?"Resource efficiency: "Show me which Kubernetes clusters are below
More news about: CloudZero
Dec 01, 2025, 09:34 ET Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
/PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission (EC) has granted Marketing Authorization (MA) for Winlevi® (clascoterone 10 mg/g cream), following the positive opinion issued by the European Medicines
More news about: Glenmark Pharmaceuticals
Dec 01, 2025, 09:31 ET Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
/PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission (EC) has granted Marketing Authorization (MA) for Winlevi® (clascoterone 10 mg/g cream), following the positive opinion issued by the European Medicines
More news about: Glenmark Pharmaceuticals
Dec 01, 2025, 08:30 ET Commvault Achieves AWS Resilience Competency Status
wide breadth of AWS workloads, including Amazon Simple Storage Service (Amazon S3), Amazon Elastic Compute Cloud (Amazon EC2), and Amazon DynamoDB. From readiness to protection to recovery, Commvault delivers these capabilities through the cloud-native Commvault Cloud platform
More news about: COMMVAULT
Nov 28, 2025, 20:31 ET Ecopetrol S.A. Negotiates Acquisition of a Portfolio of up to 88.2 MWp in Solar Photovoltaic Projects in Colombia
BOGOTA, Colombia, Nov. 28, 2025 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) ("Ecopetrol" and together with its subsidiaries, the "Ecopetrol Group") announces that on November 28, 2025, it successfully concluded negotiations with
More news about: Ecopetrol S.A.
Nov 28, 2025, 08:53 ET Updates from Ecopetrol S.A.'s Board of Directors
BOGOTA, Colombia, Nov. 28, 2025 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) ("Ecopetrol" or the "Company" and together with its subsidiaries, the "Ecopetrol Group") announces that, during its meeting held on November 27, 2025,
More news about: Ecopetrol S.A.